ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #3,293Hybrid

European Journal of Clinical Investigation

Acronym:ejci
•
Abbreviation (ISO):EUR. J. CLIN. INVEST
•
Identifier (ISSN):0014-2972(Print)/1365-2362(Online)
•
Publisher:Wiley-Blackwell Publishing Ltd
Clarivate IF (2026)
4.1↑ +0.5
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for European Journal of Clinical Investigation

WoS Q1
13683.0920182.7820193.4820204.6920215.7220225.520234.420243.620254.12026
Annual Impact Factor Metric
Current (2026):4.1
Scopus SJR & RankScopus Q1
1.27
#3,293

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
130

130 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation Rate2.3%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
200articles/year
49.9% Gold OA•78.43% Original Research

Aims & Scope

EJCI considers any original contribution from the most sophisticated basic molecular sciences to applied clinical and translational research and evidence-based medicine across a broad range of subspecialties. The EJCI publishes reports of high-quality research that pertain to the genetic, molecular, cellular, or physiological basis of human biology and disease, as well as research that addresses prevalence, diagnosis, course, treatment, and prevention of disease. We are primarily interested in studies directly pertinent to humans, but submission of robust in vitro and animal work is also encouraged. Interdisciplinary work and research using innovative methods and combinations of laboratory, clinical, and epidemiological methodologies and techniques is of great interest to the journal. Several categories of manuscripts (for detailed description see below) are considered: editorials, original articles (also including randomized clinical trials, systematic reviews and meta-analyses), reviews (narrative reviews), opinion articles (including debates, perspectives and commentaries); and letters to the Editor.

Topics Covered (Recognized by AI)
Medicine98.2%Biology84.4%Internal medicine84.3%Chemistry67%Endocrinology62.7%Biochemistry62.6%Genetics52.4%Pathology42%Psychology27.8%Immunology27.4%Organic chemistry26.3%Surgery24.4%Physics23.9%Cardiology21.5%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

MEDICINE, GENERAL & INTERNAL

Q1
Rank53/336
IndexSCIE
JCRSCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Q2
Rank68/191
IndexSCIE
JCISCIE2026

MEDICINE, GENERAL & INTERNAL

Q1
Rank80/336
IndexSCIE
JCISCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Q2
Rank75/191
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF4.1
Articles / Year104
Total Citations54
2025
IF3.6
Articles / Year209
Total Citations844
2024
IF4.4
Articles / Year238
Total Citations1,685
2023
IF5.5
Articles / Year211
Total Citations1,995
2022
IF5.722
Articles / Year224
Total Citations3,070

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #3,293Scopus Q1SCImago Profile
Scopus Coverage:1970-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q1
1.27

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
4.02

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,468 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,368
3-Year Documents614
Citable Documents520

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate39.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

BiochemistryQ1
Clinical BiochemistryQ1
Medicine (miscellaneous)Q1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
2区MEDICINE, GENERAL & INTERNAL
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

European Journal of Clinical Investigation (acronym: ejci, abbr: EUR. J. CLIN. INVEST, ISSN: 0014-2972) is a peer-reviewed international scholarly journal in the field of Medicine, published by Wiley-Blackwell Publishing Ltd in Germany since 1970. The periodical holds a Journal Impact Factor (JIF) of 4.10, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.270 (Q1), an H-index of 130.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 200 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,468 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Wiley-Blackwell Publishing Ltd
Publication Language
English
Frequency
Monthly
Founding Year
1970
Indexing & Databases
SCIEScopusPubMed
Editorial Address
WILEY-BLACKWELL PUBLISHING, INC, COMMERCE PLACE, 350 MAIN ST, MALDEN, USA, MA, 02148

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 636d5d52-6ed6-4aff-8f82-d5e70c2bfdb2
Database Updated: 2026-10-01